Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
ALDX holding history
Aldeyra Therapeutics, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −299,669−100.0% | Sold out | Holders |
| Q2 2024 | 299,669 | $991.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 299,669 | $979.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 299,669 | $1.05M | <0.1% | −95,165−24.1% | Reduced | Holders |
| Q3 2023 | 394,834 | $2.64M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 394,834 | $3.31M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 394,834 | $3.92M | 1.3% | 00.0% | Unchanged | Holders |
| Q4 2022 | 394,834 | $2.75M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2022 | 394,834 | $2.11M | 0.6% | 00.0% | Unchanged | Holders |
| Q2 2022 | 394,834 | $1.57M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 394,834 | $1.75M | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 394,834 | $1.58M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 394,834 | $3.47M | 0.3% | – | No prior filing | Holders |